|
LYSMD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.043600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.422200E-01 |
| Normal-vs-Stage2 |
6.659800E-01 |
| Normal-vs-Stage3 |
3.360800E-03 |
| Normal-vs-Stage4 |
1.737560E-02 |
| Stage1-vs-Stage2 |
6.524400E-01 |
| Stage1-vs-Stage3 |
1.435290E-03 |
| Stage1-vs-Stage4 |
1.338020E-02 |
| Stage2-vs-Stage3 |
2.232100E-02 |
| Stage2-vs-Stage4 |
4.491800E-02 |
| Stage3-vs-Stage4 |
7.694000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.518600E-01 |
| Normal-vs-AfricanAmerican |
1.720590E-01 |
| Normal-vs-Asian |
7.505200E-01 |
| Caucasian-vs-AfricanAmerican |
5.063600E-01 |
| Caucasian-vs-Asian |
9.420200E-01 |
| AfricanAmerican-vs-Asian |
7.214800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.939640E-01 |
| Normal-vs-Female |
3.686400E-01 |
| Male-vs-Female |
7.019400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.685000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.972000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.182300E-02 |
| Normal-vs-Age(81-100Yrs) |
9.675800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.469200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.560800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.886000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.025770E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.244200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.606200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.075000E-01 |
| Normal-vs-Grade 2 |
5.554000E-01 |
| Normal-vs-Grade 3 |
7.388400E-02 |
| Normal-vs-Grade 4 |
1.371160E-04 |
| Grade 1-vs-Grade 2 |
2.179600E-01 |
| Grade 1-vs-Grade 3 |
3.585700E-02 |
| Grade 1-vs-Grade 4 |
7.437000E-04 |
| Grade 2-vs-Grade 3 |
9.783400E-03 |
| Grade 2-vs-Grade 4 |
2.05379999999034E-05 |
| Grade 3-vs-Grade 4 |
2.153900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.346300E-02 |
| Normal-vs-ccB subtype |
2.05709999999693E-05 |
| ccA subtype-vs-ccB subtype |
2.23665530540984E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.500600E-01 |
| Normal-vs-N1 |
1.222780E-01 |
| N0-vs-N1 |
4.971200E-01 |
|
|
